Yoshimasa Jo

1.8k total citations
37 papers, 1.4k citations indexed

About

Yoshimasa Jo is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Yoshimasa Jo has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Surgery. Recurrent topics in Yoshimasa Jo's work include Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (15 papers) and MRI in cancer diagnosis (8 papers). Yoshimasa Jo is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (17 papers), Prostate Cancer Treatment and Research (15 papers) and MRI in cancer diagnosis (8 papers). Yoshimasa Jo collaborates with scholars based in Japan and United States. Yoshimasa Jo's co-authors include Tsutomu Tamada, Teruki Sone, Akira Yamamoto, Katsuyoshi Ito, Tomohiro Fujii, Yoshiyuki Miyaji, Takenori Yamashita, Masao Fukunaga, Atsushi Nagai and Ryoei Hara and has published in prestigious journals such as PLoS ONE, Oncogene and Radiology.

In The Last Decade

Yoshimasa Jo

37 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yoshimasa Jo 1.0k 607 290 228 158 37 1.4k
GERALD W. HULL 1.0k 1.0× 103 0.2× 307 1.1× 232 1.0× 71 0.4× 13 1.2k
Tom Claeys 1.1k 1.1× 526 0.9× 131 0.5× 189 0.8× 22 0.1× 29 1.4k
Hiromichi Ishiyama 881 0.9× 190 0.3× 64 0.2× 396 1.7× 100 0.6× 103 1.3k
R. Tarabuzzi 810 0.8× 198 0.3× 59 0.2× 336 1.5× 101 0.6× 42 1.2k
Daryl Lim Joon 1.0k 1.0× 446 0.7× 77 0.3× 405 1.8× 25 0.2× 96 1.7k
Alberto Lapini 1.2k 1.2× 142 0.2× 162 0.6× 561 2.5× 271 1.7× 91 1.8k
Kenta Miki 465 0.5× 92 0.2× 105 0.4× 110 0.5× 96 0.6× 71 666
Joycelyn L. Speight 1.1k 1.1× 246 0.4× 102 0.4× 195 0.9× 35 0.2× 43 1.3k
Adilson Prando 680 0.7× 297 0.5× 199 0.7× 263 1.2× 66 0.4× 62 1.1k
Anas M. El‐Mahdi 876 0.9× 181 0.3× 192 0.7× 403 1.8× 82 0.5× 69 1.3k

Countries citing papers authored by Yoshimasa Jo

Since Specialization
Citations

This map shows the geographic impact of Yoshimasa Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimasa Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimasa Jo more than expected).

Fields of papers citing papers by Yoshimasa Jo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimasa Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimasa Jo. The network helps show where Yoshimasa Jo may publish in the future.

Co-authorship network of co-authors of Yoshimasa Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimasa Jo. A scholar is included among the top collaborators of Yoshimasa Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimasa Jo. Yoshimasa Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jo, Yoshimasa, Tomohiro Fujii, Ryoei Hara, et al.. (2011). Salvage high‐dose‐rate brachytherapy for local prostate cancer recurrence after radiotherapy – preliminary results. British Journal of Urology. 109(6). 835–839. 37 indexed citations
3.
Nagahara, Akira, Masashi Nakayama, Daizo Oka, et al.. (2009). SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochemical and Biophysical Research Communications. 391(4). 1641–1646. 24 indexed citations
4.
Hara, Ryoei, Yoshimasa Jo, Tomohiro Fujii, et al.. (2008). Optimal Approach for Prostate Cancer Detection as Initial Biopsy: Prospective Randomized Study Comparing Transperineal Versus Transrectal Systematic 12-Core Biopsy. Urology. 71(2). 191–195. 129 indexed citations
5.
Tamada, Tsutomu, Teruki Sone, Yoshimasa Jo, et al.. (2008). Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade. Journal of Magnetic Resonance Imaging. 28(3). 720–726. 208 indexed citations
6.
Nagai, Atsushi, Ryoei Hara, Teruhiko Yokoyama, et al.. (2008). Ejaculatory dysfunction caused by the new α1‐blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography. International Journal of Urology. 15(10). 915–918. 36 indexed citations
7.
Tamada, Tsutomu, Teruki Sone, Shinya Toshimitsu, et al.. (2008). Age‐related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. Journal of Magnetic Resonance Imaging. 27(3). 552–556. 52 indexed citations
8.
Ishimura, Takeshi, Atsushi Takenaka, Yutaka Sakai, et al.. (2006). Hydronephrosis caused by intra‐abdominal abscess from cecal perforation by an ingested fish bone. International Journal of Urology. 13(10). 1350–1351. 6 indexed citations
9.
Jo, Yoshimasa, et al.. (2005). Radical prostatectomy versus high‐dose rate brachytherapy for prostate cancer: effects on health‐related quality of life. British Journal of Urology. 96(1). 43–47. 32 indexed citations
10.
Ozawa, Heita, Satoshi Ashizawa, Masanori Naito, et al.. (2004). Paired-like homeodomain protein ESXR1 possesses a cleavable C-terminal region that inhibits cyclin degradation. Oncogene. 23(39). 6590–6602. 15 indexed citations
12.
13.
Tamada, Tsutomu, et al.. (2004). T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spin-echo imaging. European Radiology. 14(2). 318–325. 19 indexed citations
14.
Hiratsuka, Junichi, et al.. (2004). Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 59(3). 684–690. 53 indexed citations
15.
Tamada, Tsutomu, Teruki Sone, T Tomomitsu, et al.. (2001). Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy. Journal of Bone and Mineral Metabolism. 19(1). 45–51. 52 indexed citations
16.
Jo, Yoshimasa, et al.. (2001). Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract. International Journal of Urology. 8(7). 366–373. 25 indexed citations
18.
Kobayashi, Tatsuya, et al.. (2000). CLINICAL EVALUATION OF LOW DOSE GLUCOCORTICOID THERAPY FOR HORMONE-REFRACTORY PROSTATE CANCER. The Japanese Journal of Urology. 91(4). 479–484. 2 indexed citations
19.
Matsuki, Takakazu, et al.. (2000). FAMILIAL ISOLATED HYPERPARATHYROIDISM: A REPORT OF TWO CASES. The Japanese Journal of Urology. 91(1). 33–36. 3 indexed citations
20.
Hyodo, Fuminori, et al.. (1998). Establishment and Characterization of a New Human Testicular Seminoma Cell Line, JKT‐1. International Journal of Urology. 5(3). 282–287. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026